Harokopio University
hua.grTotal trials
64
Active
7
Phase 3
1
Total enrollment
18,327
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Metabolic Syndrome4
- Obesity4
- Cardiometabolic Health3
- Oxidative Stress3
- Appetite3
- Overweight and Obesity3
- Healthy3
- Type 2 Diabetes Mellitus2
Frequently asked questions about Harokopio University
- How many clinical trials does Harokopio University have on ClinicalTrials.gov?
- Harokopio University is listed as the lead sponsor on 64 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Harokopio University's trials are in Phase 3?
- 1 of Harokopio University's trials are in Phase 3.
- What therapeutic areas does Harokopio University focus on?
- Harokopio University's most-studied conditions on ClinicalTrials.gov are Metabolic Syndrome, Obesity, Cardiometabolic Health, Oxidative Stress, Appetite.